The global pharmacogenomics (PGX) market size was valued at USD 6.13 billion in 2024 and is projected to grow from USD 6.69 billion in 2025 to USD 11.17 billion by 2033, exhibiting a CAGR of 6.6% during the forecast period (2025-2033).
Market Scope and Research Methodology
This report provides an in-depth analysis of the Pharmacogenomics (PGX) Market at global, regional, and country levels. It examines market size, regional performance, and competitive strategies of leading companies, supported by a SWOT analysis. The study uses a robust methodology combining primary and secondary research with validated forecasting techniques to deliver accurate and reliable market insights.
The main goal of this report is to offer actionable insights into Pharmacogenomics (PGX) Market trends, growth drivers, and key factors affecting industry performance. It covers market structure, segmentation, and projected market value, while identifying growth opportunities, challenges, and trends shaped by technology, regulations, cost efficiency, and changing consumer demand.
Download Sample Report PDF
https://straitsresearch.com/report/pharmacogenomics-market/request-sample
Regional Insights
The report provides detailed analysis across major regions, including North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Each region is evaluated for Pharmacogenomics (PGX) Market size, growth trends, trade patterns, and overall industry maturity. This segmentation helps identify competitive strengths and untapped growth potential in each region.
Market Segmentation
- By Type
- Products
- Genotyping Kits
- Sequencing Instruments
- PCR Reagents and Consumables
- Sample Preparation Kits
- Others
- Services
- Genetic Testing Services
- Pharmacogenomic Consulting
- Others
- Software
- Bioinformatics Software
- Clinical Decision Support System
- Laboratory Information Management System
- EHR Integration Software
- Others
- Products
- By Technology
- Next-Generation Sequencing
- Polymerase Chain Reaction
- Mass Spectrometry
- Microarray
- Others
- By Application
- Cardiovascular disease
- Infectious diseases
- Oncology
- Neurological diseases
- Pain Management and Trauma
- Others
- By End-User
- Hospitals
- Clinical Laboratories
- Pharmaceutical Companies
- Academic Research Institutions
- Others
Key Market Players
- QIAGEN
- Illumina, Inc.
- Agilent Technologies, Inc.
- Foundation Medicine, Inc.
- Thermo Fisher Scientific Inc.
- Admera Health
- Myriad Genetics, Inc.
- Beckman Coulter, Inc.
- OneOme
- Genomind
- Coriell Life Sciences
- PGxAI
- Tempus
- DEEP GENOMICS
- Helix, Inc.
- Oxford Nanopore Technologies plc.
Download Sample Report PDF
https://straitsresearch.com/report/pharmacogenomics-market/request-sample
Key Questions Answered in the Report
What is the market overview of the Pharmacogenomics (PGX) Market?
What was the market size in 2024?
What is the projected CAGR during the forecast period?
Which factors are driving market growth?
How is the market segmented?
What strategies are adopted by leading companies?
Which trends and applications are shaping industry development?
Who are the top participants in the market?
What are the key capabilities and product offerings of leading companies?
About Us
Straits Research has over 10 years of experience providing data-driven insights to more than 2,025 organizations worldwide, from startups to global enterprises. Our syndicated research reports cover high-impact industries such as chemicals, food and beverages, healthcare, automotive, technology, aerospace, and defense. We also offer customized research solutions to support strategic decision-making and business growth.
